ProleUkIn.com offers treatment for bacterial endocarditis
Title
PROLEUKIN® IL-2 Therapy (aldesleukin): Metastatic Renal Cell Carcinoma and Metastatic Melanoma Treatment
Description
PROLEUKIN® IL-2 therapy (aldesleukin) is indicated for the treatment of metastatic renal cell carcinoma (metastatic kidney cancer) and metastatic melanoma (a type of skin cancer).